Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
15 studies found for:    "Autoimmune hemolytic anemia"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Safety and Efficacy Study of R935788 in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (AIHA)
Condition: Warm Antibody Autoimmune Hemolytic Anemia
Interventions: Drug: Fostamatinib 150 mg bid;   Drug: Fostamatinib 100 mg bid
2 Recruiting Immunopathology of Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Intervention: Biological: blood samples
3 Recruiting Study the Role of T Lymphocytes in Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Anemia
Intervention: Biological: blood sample
4 Active, not recruiting Rituximab in Auto-Immune Hemolytic Anemia
Condition: Warm Autoimmune Hemolytic Anemia
Interventions: Drug: rituximab (Mabthera®);   Drug: Placebo
5 Completed Treatment of Autoimmune Thrombocytopenia (AITP)
Conditions: Autoimmune Disease;   Autoimmune Hemolytic Anemia;   Thrombocytopenia
Intervention: Device: Isolex 300i
6 Not yet recruiting Evaluating the Interest of Interleukine-2 for Patients With Active Warm Hemolytic Anemia Resistant to Conventional Treatment
Condition: Autoimmune Hemolytic Anemia
Intervention: Drug: Interleukine-2
7 Unknown  Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.
Conditions: Anemia;   Anemia, Hemolytic;   Anemia, Hemolytic, Autoimmune;   Hemolysis;   Hematologic Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes
Interventions: Drug: levamisole;   Drug: Prednisone
8 Recruiting Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Conditions: Cold Agglutinin Disease;   Autoimmune Hemolytic Anemia
Intervention: Drug: Bendamustine, Rituximab
9 Recruiting Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
Conditions: Bullous Pemphigoid (BP);   Cold Agglutinin Disease;   Warm Autoimmune Hemolytic Anemia;   End-stage Renal Disease (ESRD)
Interventions: Drug: TNT009;   Other: Placebo
10 Completed A Single-Arm Pilot Study With Low-Dose Rituximab Plus Standard Oral Prednisone In Idiopathic Autoimmune Hemolytic Anemia
Condition: Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
Intervention: Drug: prednisone, low dose rituximab
11 Completed Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
Condition: Anemia, Hemolytic, Autoimmune
Interventions: Drug: prednisolone + mabthera;   Drug: Prednisolone
12 Completed The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Conditions: Pemphigus;   Auto-immune Thrombocytopenic Purpura;   Hemolytic Auto-immune Anaemia;   Cold Agglutinin Disease;   Cryoglobulinemia
Intervention: Drug: Rituximab (MABTHERA® or RITUXAN®).
13 Completed Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter's Transformation (RT)
Condition: Chronic Lymphocytic Leukemia
Interventions: Biological: rituximab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate
14 Completed Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
Conditions: Anemia, Hemolytic, Autoimmune;   Felty Syndrome;   Purpura, Thrombocytopenic;   Autoimmune Diseases
Interventions: Drug: cyclophosphamide;   Drug: filgrastim
15 Unknown  Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases
Conditions: Purpura, Schoenlein-Henoch;   Graft Versus Host Disease;   Anemia, Hemolytic, Autoimmune;   Rheumatoid Arthritis;   Churg-Strauss Syndrome;   Hypersensitivity Vasculitis;   Wegener's Granulomatosis;   Systemic Lupus Erythematosus;   Giant Cell Arteritis;   Pure Red Cell Aplasia;   Juvenile Rheumatoid Arthritis;   Polyarteritis Nodosa;   Autoimmune Thrombocytopenic Purpura;   Takayasu Arteritis
Interventions: Drug: anti-thymocyte globulin;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: filgrastim;   Drug: methylprednisolone;   Drug: prednisone;   Procedure: Autologous Peripheral Blood Stem Cell Transplantation

Indicates status has not been verified in more than two years